ORX:STO
Orexo AB
SEKÂ 5.94
arrow_upward
+0.68%(+0.040) 1D
Oct 16, 5:29:58 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 5.88
High
SEKÂ 6.19
Low
SEKÂ 5.74
Mkt. cap
208.65M
Avg. vol.
115.34K
Volume
0.00
P/E ratio
0.25
52-wk high
SEKÂ 40.15
52-wk low
SEKÂ 5.74
EPS
SEKÂ 23.61
Shares outstanding
35.13M
No. of employees
61
Open
SEKÂ 5.88
High
SEKÂ 6.19
Low
SEKÂ 5.74
Mkt. cap
208.65M
Avg. vol.
115.34K
Volume
0.00
P/E ratio
0.25
52-wk high
SEKÂ 40.15
52-wk low
SEKÂ 5.74
EPS
SEKÂ 23.61
Shares outstanding
35.13M
No. of employees
61
News stories
From web sources and news partners
Opening Bell Daily
·
10 minutes ago
Stock market after midterms: S&P 500 up all 19 times
Simply Wall Street
·
51 minutes ago
Aura Minerals (NasdaqGS:AUGO) Shares Just Moved, So What Is Going On?
Foreign Policy Journal
·
41 minutes ago
Options Pricing Points To 9% Swing For Netflix (NASDAQ: NFLX) Stock Following Upcoming Earnings Report
Yahoo Finance
·
10 hours ago
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees61
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteorexo.com